Video Experimental Relacionado
Updated: Jan 20, 2026
08:27
Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease
Published on: September 20, 2018
8.1K
Terapia de mesalazina mejorada con nanopartículas para la enfermedad inflamatoria intestinal
Rajvanshi Sutaria1, Zi Hong Mok1
1Swansea University Medical School, Swansea, UK.
Pharmaceutical science advances
|January 19, 2026
Resumen
La nanotecnología mejora la administración de mesalazina para la enfermedad inflamatoria intestinal (EII). La nanoencapsulación mejora la focalización y absorción del fármaco, ofreciendo un enfoque prometedor para el tratamiento de la colitis ulcerosa y la enfermedad de Crohn.
Área de la Ciencia:
- Gastroenterología y Nanomedicina
Sus antecedentes:
- La enfermedad inflamatoria intestinal (EII) abarca la inflamación crónica del tracto gastrointestinal, incluida la colitis ulcerosa (CU) y la enfermedad de Crohn (EC).
- Los tratamientos actuales con mesalazina enfrentan desafíos en la administración dirigida del fármaco y a menudo causan efectos secundarios sistémicos adversos.
- La administración local eficaz de aminosalicilatos como la mesalazina a las áreas inflamadas sigue siendo un obstáculo importante en el manejo de la EII.
Objetivo del estudio:
- Revisar la comprensión actual de la EII.
- Explorar estrategias nanotecnológicas para mejorar la terapia con mesalazina en la EII.
- Destacar el potencial de los nanotransportadores para mejorar la focalización y la farmacocinética del fármaco.
Principales métodos:
- Revisión de la literatura sobre EII, formulaciones de mesalazina y aplicaciones de nanotransportadores.
- Análisis de estudios sobre la nanoencapsulación de mesalazina utilizando nanotransportadores lipídicos, poliméricos y inorgánicos.
- Evaluación del impacto de los nanotransportadores en la solubilidad, absorción, biodisponibilidad y perfiles de efectos secundarios del fármaco.
Principales resultados:
- La nanoencapsulación de mesalazina demuestra una focalización exitosa de las regiones inflamatorias en la EII.
- Los nanotransportadores mejoran la solubilidad, absorción y biodisponibilidad de la mesalazina.
- Varios tipos de nanotransportadores (lipídicos, poliméricos, inorgánicos) ofrecen ventajas distintas para la administración de fármacos.
Conclusiones:
- La nanotecnología ofrece una vía prometedora para mejorar la eficacia de la mesalazina en el tratamiento de la EII de leve a moderada.
- La nanoencapsulación minimiza la absorción sistémica y los efectos secundarios asociados de la mesalazina.
- La investigación adicional sobre sistemas de nanotransportadores puede optimizar la terapia con mesalazina para pacientes con EII.
Videos de Conceptos Relacionados
08:27Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease
8.1K
Dynamic adhesion of immune cells to the vessel wall is a prerequisite for gut homing. Here, we present a protocol for a functional in vitro assay for the impact analysis of anti-integrin antibodies, chemokines or other factors on the dynamic cell adhesion of human cells using addressin-coated...
8.1K
01:30Inflammatory Bowel Disease II: Crohn's Disease
971
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
971
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
645
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
645
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
908
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
908
01:21Inflammatory Bowel Disease V: Surgical Management
458
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
458
01:33Nanoparticle-Mediated Enhanced Delivery of an Anti-Inflammatory Drug in Microglia-Like Cells
311
Take cultures of human monocyte-derived microglia-like cells.Introduce nanoparticles containing an anti-inflammatory drug into the experimental culture and the free drug into the control.The nanoparticles feature a hydrophilic shell and a hydrophobic core encapsulating the lipophilic drug.The cells endocytose the nanoparticles, which release the drug intracellularly, enhancing its delivery.The free drug enters by passive diffusion, a process constrained by the concentration gradient, which...
311